The National Institute for Health and Care Excellence has now approved capivasertib for use on the NHS - we look at who could ...

Capivasertib is used to treat incurable breast cancer and has shown to have slowed the disease down. The twice-a-day pill, which is for the most common type of advanced breast can ...

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

The UK National Institute for Health and Care Excellence has recommended a targeted twice daily drug treatment that could help around 3000 women a year with advanced breast cancer in England and Wales ...

A breakthrough cancer drug for those facing the advanced stages of the disease has been approved for the first time on the ...

A "huge breakthrough" in breast cancer treatment has arrived with the NHS approval of a twice-daily pill for the most common form of advanced disease. At such a critical moment in US history, we need ...

Experts believe the new drug, capivasertib, could help more than 1,000 women with an advanced type of breast cancer. A “game-changing” new treatment for advanced breast cancer is being made ...

A twice-a-day pill for advanced breast cancer has been approved for use on the NHS. The life-extending drug, called ...

Hundreds of women suffering from incurable breast cancer have been given a glimmer of hope as a treatment costing £77,000 per ...